Cagrilintide is not approved for any indication anywhere
A., Kemmeries, G., Holst, J
Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
2010 Mar 3;15(3):1242-64. [PMID: 20335977]
BPC-157 Dosage for Injury In research studies, scientists have to be very careful with how much they use
In cosmetics and topical applications, GHK-Cu may help promote tightening of loose skin, skin elasticity and firmness, wrinkle reduction, and photoprotection (mitigation of sun damage)